| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| ccr4 inhibitor | 1.17 | 0.6 | 9661 | 21 | 14 |
| ccr4 | 0.87 | 1 | 9767 | 60 | 4 |
| inhibitor | 1.96 | 0.4 | 394 | 98 | 9 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| ccr4 inhibitor | 1.37 | 0.2 | 7915 | 58 |
| ccr4 inhibitor clinical trial | 0.97 | 0.7 | 6815 | 95 |
| ccr2 inhibitor clinical trial | 0.2 | 0.1 | 2656 | 18 |
| cdk4/6 inhibitor clinical trial | 0.18 | 0.9 | 7379 | 10 |
| src inhibitor clinical trial | 1.33 | 0.3 | 2267 | 14 |
| cxcr4 antibody clinical trial | 1.1 | 0.5 | 9669 | 55 |
| brd4 inhibitor clinical trial | 0.16 | 0.2 | 3598 | 17 |
| ccr8 antibody clinical trial | 1.78 | 0.9 | 8192 | 16 |
| anti-ccr1 antibody clinical trial | 1.68 | 0.9 | 5835 | 69 |
| ccr2 antagonist clinical trials | 1.73 | 0.7 | 4846 | 59 |
| ep4 inhibitor clinical trial | 1.5 | 0.7 | 8571 | 26 |
| pad4 inhibitor clinical trial | 0.75 | 0.7 | 6674 | 64 |
| ccr4 in thyroid cancer | 0.78 | 0.6 | 351 | 60 |
| ddr1 inhibitor clinical trial | 0.93 | 0.7 | 7458 | 38 |
| clk inhibitor clinical trial | 0.04 | 0.5 | 7282 | 88 |
| irak4 inhibitor clinical trial | 0.68 | 1 | 7550 | 71 |
| cdk2 inhibitor clinical trial | 0.62 | 1 | 3207 | 83 |
| crc in clinical trial | 0.16 | 0.2 | 9211 | 95 |
| vrk1 inhibitor clinical trial | 1.95 | 0.2 | 6785 | 37 |
| bcl6 inhibitor clinical trial | 1.76 | 0.9 | 4724 | 83 |
| anti-ccr4 | 1.62 | 0.4 | 8529 | 19 |
